Capital Flow Monitor · Sponsors · CIK 2096367
Regenimo Biosciences, Inc.
3262 WESTHEIMER RD. #762, HOUSTON, TX, 77098 · 7137022100
Biotechnology · Corporation· inc. DELAWARE true 2025
Fit score
—
Offering
$2.0M
Sold
$2.0M
% sold
100.0%
Investors
6
Min investment
$50K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-11-25 | D ·current | 506(b) | $2.0M | $2.0M | 100.0% | 6 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Sharon Shacham — Executive Officer / Director, Houston, TX
1 other raise
- Nasus Pharma Ltd $15.0M of $15.0M · 100.0%
-
Lynda Chin — Director, Houston, TX
1 other raise
- Bectas Therapeutics, Inc. $5.6M of $10.0M · 55.5%
- Raju Kucherlapati — Director, Houston, TX
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.